LEO Pharma closes Bayer’s prescription dermatology unit deal in US
LEO Pharma has completed the acquisition of Bayer’s prescription dermatology portfolio in the US. The deal is expected to also…
LEO Pharma
-
-
LEO Pharma to develop and commercialise JW Pharmaceutical’s JW1601
Denmark-based LEO Pharma has entered a global licensing agreement to develop and commercialise South Korean JW Pharmaceutical’s JW1601 drug candidate…
-
LEO Pharma to acquire Bayer’s prescription dermatology portfolio
Denmark-based LEO Pharma has signed a definitive agreement to acquire Bayer’s global prescription dermatology unit in a bid to expand…
